Belarus vs Nepal: HIV/AIDS deaths averted by antiretroviral therapy
Belarus
1,203 deaths
in 2022
Nepal
1,348 deaths
in 2024
Belarus rank
71st
Nepal rank
69th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Belarus
- Nepal
How they compare
Nepal currently reports 1,348 deaths against 1,203 deaths in Belarus, a difference of 145 deaths.
That makes Nepal's figure about 1.1 times Belarus's.
The two have swapped places 2 times across 33 shared years of data; in 1990 it was Nepal ahead.
Belarus ranks 71st and Nepal ranks 69th of 157 countries.
Nepal has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Belarus | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 70.2 deaths | 175.89 deaths | 105.69 deaths | Nepal |
| 2010s | 703.4 deaths | 1,151 deaths | 447.1 deaths | Nepal |
| 2020s | 1,184 deaths | 1,323 deaths | 139.59 deaths | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Belarus or Nepal?
- Nepal, at 1,348 deaths against 1,203 deaths in Belarus as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Belarus and Nepal?
- 145 deaths, with Nepal ahead.
- How many years of comparable data are there for Belarus and Nepal?
- 33 years are reported by both, from 1990 to 2022.
- How do Belarus and Nepal rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Belarus ranks 71st and Nepal ranks 69th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.